These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 197704)

  • 1. Transcription of latent Epstein--Barr virus genomes in human epithelial/Burkitt hybrid cells.
    Tanaka A; Nonoyama M; Glaser R
    Virology; 1977 Oct; 82(1):63-8. PubMed ID: 197704
    [No Abstract]   [Full Text] [Related]  

  • 2. Transcription of Epstein-Barr virus genomes in human lymphoblastoid cells and in somatic-cell hybrids of Burkitt's lymphoma.
    Nonoyama M; Tanaka A; Silver S; Glaser R
    IARC Sci Publ (1971); 1978; (24 Pt 1):559-63. PubMed ID: 221360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of latent Epstein-Barr virus genomes in human epithelial/Burkitt's lymphoblastoid hybrid cells.
    Nonoyama M; Tanaka A; Glaser R
    IARC Sci Publ (1971); 1978; (20):397-402. PubMed ID: 215523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic cell hybrids between human lymphoma and human myeloid leukemia cells. I. Induction of resident viral genome transcription and viral antigen formation by IUDR and TPA.
    Lau RY; Nonoyama M; Klein G
    Virology; 1981 Apr; 110(2):259-69. PubMed ID: 6261446
    [No Abstract]   [Full Text] [Related]  

  • 5. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle in a new set of somatic cell hybrids.
    Klein G; Clements G; Zeuthen J; Westman A
    Cancer Lett; 1977 Jul; 3(1-2):91-8. PubMed ID: 196751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus activation of human epithelial-nasopharyngeal carcinoma hybrid cells.
    Takimoto T; Umeda R; Ogura H; Hatano M
    Am J Otolaryngol; 1984; 5(1):1-6. PubMed ID: 6099983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rescue of Epstein-Barr virus from somatic cell hybrids of Burkitt lymphoblastoid cells.
    Glaser R; Rapp F
    J Virol; 1972 Aug; 10(2):288-96. PubMed ID: 4342246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of Epstein-Barr virus antigens and DNA in activated Burkitt somatic cell hybrids.
    Glaser R; Nonoyama M; Decker B; Rapp F
    Virology; 1973 Sep; 55(1):62-9. PubMed ID: 4353957
    [No Abstract]   [Full Text] [Related]  

  • 9. Epstein-Barr virus-regulation studies on somatic-cell hybrids derived from the fusion of Burkitt's lymphoma and nasopharyngeal carcinoma cells with human or mouse partners.
    Klein G
    IARC Sci Publ (1971); 1978; (20):369-76. PubMed ID: 215519
    [No Abstract]   [Full Text] [Related]  

  • 10. Epstein-Barr virus: detection of genome in somatic cell hybrids of Burkitt lymphoblastoid cells.
    Glaser R; Nonoyama M
    Science; 1973 Feb; 179(4072):492-3. PubMed ID: 4350214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential activation by cell fusion of Epstein-Barr viral and type-C viral genomes in non-productive human lymphoid cells.
    Yamamoto K; Matsuo T; Osato T
    Arch Virol; 1975; 48(2):187-90. PubMed ID: 167693
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on an epithelial/Burkitt hybrid cell line prepared from a lymphoblastoid cell line with one EBV genome equivalent per cell.
    Glaser R; Nonoyama M; Whitman M; Forcino T
    Virology; 1979 Oct; 98(1):272-4. PubMed ID: 225868
    [No Abstract]   [Full Text] [Related]  

  • 13. Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells.
    Wolf J; Pawlita M; Klevenz B; Frech B; Freese UK; Müller-Lantzsch N; Diehl V; zur Hausen H
    Int J Cancer; 1993 Feb; 53(4):621-7. PubMed ID: 8382194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dibutyryl cyclic AMP on the induction of Epstein-Barr virus in hybrid cells.
    Zimmerman JE; Glaser R; Rapp F
    J Virol; 1973 Dec; 12(6):1442-5. PubMed ID: 4357515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial elimination of latent Epstein-Barr virus genomes from virus-producing cells by cyclohexamide.
    Tanaka A; Nonoyama M; Hampar B
    Virology; 1976 Mar; 70(1):164-70. PubMed ID: 176800
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of adenine arabinoside on Epstein-Barr virus in vitro.
    Coker-Vann M; Dolin R
    J Infect Dis; 1977 Mar; 135(3):447-53. PubMed ID: 191542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between Epstein-Barr virus genome number, amount of nuclear antigen, and early antigen inducibility in diploid and tetraploid lymphoma cells of related origin.
    Shapiro IM; Luka J; Andersson-Anvret M; Klein G
    Intervirology; 1979; 12(1):19-25. PubMed ID: 227812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time of synthesis and cellular location of Epstein-Barr virus-specified polypeptides radioimmunoprecipitated from iododeoxyuridine-induced Burkitt lymphoma/somatic cell hybrids.
    Durnford JM; Scanlon PA; Glaser R
    J Gen Virol; 1982 May; 60(Pt 1):39-48. PubMed ID: 6284867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell surface markers on epithelial-Burkitt hybrid cells superinfected with Epstein-Barr virus.
    Glaser R; Lenoir G; Ferrone S; Pellegrino MA; de-Thé G
    Cancer Res; 1977 Jul; 37(7 Pt 1):2291-6. PubMed ID: 193641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the host cell on the maintenance and replication of Epstein-Barr virus.
    Glaser R; Farrugia R; Brown N
    Virology; 1976 Jan; 69(1):132-42. PubMed ID: 174288
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.